September 15, 2020 at 3:26 pm

MISSING: Transparence in Clinical Drug Trials

Whether it’s acne drugs, anxiety drugs, asthma drugs or possible COVID-19 cures, MISSD believes transparency in sharing clinical trial data is necessary to reduce adverse drug effects and related deaths.

Read the full Kaiser Health News article at